About Technology Issues FAQ

Links

Complete Remission Achieved With Single Agent CNTO 328, an Anti–IL-6 Monoclonal Antibody, in Relapsed and Refractory Myeloma

Complete Remission Achieved With Single Agent CNTO 328, an Anti–IL-6 Monoclonal Antibody, in Relapsed and Refractory Myeloma — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.